首页|快速康复外科理念在骨科手术室的应用效果

快速康复外科理念在骨科手术室的应用效果

扫码查看
目的 分析快速康复外科理念在骨科手术室中应用效果.方法 选取为2021年7月至2023年6月接受手术治疗的98例患者,按照随机数字表法分为常规组和快速康复组,每组49例.比较2组患者围手术期生理应激和并发症发生情况,并比较2组术后康复情况.结果 术前2组去甲肾上腺素(NE)、皮质醇(Cor)、促肾上腺皮质激素(ACTH)水平比较差异无统计学意义(P>0.03);术后快速康复组NE、Cor、ACTH低于常规组(P<0.05).快速康复组围手术期并发症总发生率低于常规组(P<0.05).快速康复组术后意识恢复时间、完全清醒时间、术后首次下床时间、术后恢复排气时间以及住院时长短于常规组(P<0.05),快速康复组术后24小时疼痛程度轻于常规组(P<0.05).结论 骨科手术室应用快速康复外科理念的应用效果良好,可减轻其术后生理应激反应,预防围手术期并发症的发生,有效地促进其术后康复进程.
Application effect of enhanced recovery after surgery in the orthopedic operating room
Objective To analyze the application effect of enhanced recovery after surgery(ERAS)in the orthopedic operating room.Methods A total of 98 surgically treated patients from July 2021 to June 2023 were included.They were randomly divided into the routine group and ERAS group,with 49 cases per group.Perioperative physiological stress,complications and postoperative rehabilitation were compared between groups.Results There were no significant differences in preoperative levels of norepinephrine(NE),cortisol(Cor),and adrenocorticotropic hormone(ACTH)between the two groups(P>0.05).NE,Cor,and ACTH in the ERAS group were significantly lower than those of the routine group(P<0.05).The total incidence of perioperative complications in the ERAS group was significantly lower than that of the routine group(P<0.05).Postoperative consciousness recovery time,fully awake time,first time of off-bed activities,postoperative recovery exhaust time,and length of stay were significantly shorter in the ERAS group than those of the routine group(P<0.05).Pain at 24h postoperatively was significantly milder in the ERAS group than that of the routine group(P<0.05).Conclusion ERAS is well applied in the orthopedic operating room to reduce postoperative physiologic stress,prevent perioperative complications,and effectively promote the process of postoperative recovery.

orthopedicsoperating roomenhanced recovery after surgery

夏德亚·热夏提、李丽

展开 >

830000 乌鲁木齐市,新疆医科大学第一附属医院中心手术室

骨科 手术室 快速康复外科理念

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(24)